Incyte's Gains from Sales and Divestitures rose 2500.01% to $333334.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $333334.0, marking a year-over-year increase of 2500.01%. This contributed to the annual value of $266667.0 for FY2018, which is 3333.35% up from last year.
Per Incyte's latest filing, its Gains from Sales and Divestitures stood at $333334.0 for Q3 2019, which was up 2500.01% from $333334.0 recorded in Q2 2019.
In the past 5 years, Incyte's Gains from Sales and Divestitures ranged from a high of $333334.0 in Q1 2019 and a low of $133333.0 during Q4 2015
Over the past 5 years, Incyte's median Gains from Sales and Divestitures value was $266667.0 (recorded in 2018), while the average stood at $241025.8.
As far as peak fluctuations go, Incyte's Gains from Sales and Divestitures tumbled by 6328.72% in 2015, and later surged by 5000.04% in 2017.
Incyte's Gains from Sales and Divestitures (Quarter) stood at $133333.0 in 2015, then changed by 0.0% to $133333.0 in 2016, then soared by 50.0% to $200000.0 in 2017, then soared by 33.33% to $266667.0 in 2018, then rose by 25.0% to $333334.0 in 2019.
Its Gains from Sales and Divestitures stands at $333334.0 for Q3 2019, versus $333334.0 for Q2 2019 and $333334.0 for Q1 2019.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value